Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial
- PMID: 33443907
- DOI: 10.1097/SLA.0000000000004336
Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial
Abstract
Objective: The aim of this study was to evaluate which mesh type yields lower recurrence and complication rates after ventral hernia repair.
Summary background data: More than 400,000 ventral hernia repairs are performed annually in the United States. Although the most effective method for repairing ventral hernias involves using mesh, whether to use biologic mesh versus synthetic mesh is controversial.
Methods: Single-blind, randomized, controlled, pragmatic clinical trial conducted from March 2014 through October 2018; 165 patients enrolled with an average follow up of 26 months. Patients were randomized 1:1 to have their ventral hernias repaired using either a biologic (porcine) or synthetic (polypropylene) mesh. The primary study outcome measure was hernia recurrence at 2 years.
Results: A total of 165 patients (68 men), mean age 55 years, were included in the study with a mean follow-up of 26 months. An intention-to-treat analysis noted that hernias recurred in 25 patients (39.7%) assigned to biologic mesh and in 14 patients (21.9%) assigned to synthetic mesh (P = 0.035) at 2 years. Subgroup analysis identified an increased rate of hernia recurrence in the biologic versus the synthetic mesh group under contaminated wound conditions (50.0% vs 5.9%; P for interaction = 0.041). Postoperative complication rates were similar for the 2 mesh types.
Conclusions: The risk of hernia recurrence was significantly higher for patients undergoing ventral hernia repair with biologic mesh compared to synthetic mesh, with similar rates of postoperative complications. These data indicate that the use of synthetic mesh over biologic mesh to repair ventral hernias is effective and can be endorsed, including under contaminated wound conditions.
Trial registration: ClinicalTrials.gov Identifier: NCT02041494.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Comment in
-
Comment on: Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial.Ann Surg. 2022 Nov 1;276(5):e642-e643. doi: 10.1097/SLA.0000000000005305. Epub 2021 Nov 18. Ann Surg. 2022. PMID: 34793345 No abstract available.
References
-
- Cengiz Y, Israelsson LA. Incisional hernias in midline incisions: an eight-year follow up. Hernia 1998; 2:175–177.
-
- Mudge M, Hughes LE. Incisional hernia: a 10 year prospective study of incidence and attitudes. Br J Surg 1985; 72:70–71.
-
- Regnard JF, Hay JM, Rea S, et al. Ventral incisional hernias: incidence, date of recurrence, localization and risk factors. Ital J Surg Sci 1988; 18:259–265.
-
- DeFrances CJ, Lucas CA, Buie VC, et al. 2006 National Hospital Discharge Survey. Natl Health Stat Report 2008; 1–20.
-
- Burger JW, Luijendijk RW, Hop WC, et al. Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 2004; 240:578–583. discussion 583-575.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
